ASTRAZENECA ANNOUNCES DEAL WITH VAXEQUITY TO DEVELOP DRUGS BASED ON IMPERIAL COLLEGE LONDON'S SELF-AMPLIFYING RNA PLATFORM
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Astrazeneca Announces Deal With Vaxequity To Develop Drugs Based On Imperial College London's Self-Amplifying Rna Platform